<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Fan S</submitter><funding>Natural Science Foundation of Shanghai</funding><funding>National Natural Science Foundation of China</funding><pubmed_abstract>The fungal pathogen &lt;i>Candida auris&lt;/i> has emerged as a new threat to human health. We previously reported the first isolate of &lt;i>C. auris&lt;/i> (BJCA001) in China, which belongs to the South Asian clade (I) and was susceptible to all antifungals tested. In this study, we report the isolation of a drug-resistant &lt;i>C. auris&lt;/i> strain (BJCA002) from the same city (Beijing). Strain BJCA002 belongs to the South African clade (III) and is resistant to fluconazole and amphotericin B based on the tentative MIC breakpoints. Taking advantage of the two isolates with distinct antifungal susceptibility and genetic origins, we performed a biological and genomic comparative study. Besides antifungal susceptibility, strains BJCA001 and BJCA002 showed differences in multiple aspects including morpholo</pubmed_abstract><journal>Virulence</journal><pagination>1388-1399</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8172162</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of &lt;i>Candida auris&lt;/i> isolated from Beijing, China.</pubmed_title><pmcid>PMC8172162</pmcid><pubmed_authors>Zhan P</pubmed_authors><pubmed_authors>Bing J</pubmed_authors><pubmed_authors>Hu T</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Huang G</pubmed_authors><pubmed_authors>Du H</pubmed_authors><pubmed_authors>Jiang N</pubmed_authors><pubmed_authors>Fan S</pubmed_authors><pubmed_authors>Chen D</pubmed_authors></additional><is_claimable>false</is_claimable><name>A biological and genomic comparison of a drug-resistant and a drug-susceptible strain of &lt;i>Candida auris&lt;/i> isolated from Beijing, China.</name><description>The fungal pathogen &lt;i>Candida auris&lt;/i> has emerged as a new threat to human health. We previously reported the first isolate of &lt;i>C. auris&lt;/i> (BJCA001) in China, which belongs to the South Asian clade (I) and was susceptible to all antifungals tested. In this study, we report the isolation of a drug-resistant &lt;i>C. auris&lt;/i> strain (BJCA002) from the same city (Beijing). Strain BJCA002 belongs to the South African clade (III) and is resistant to fluconazole and amphotericin B based on the tentative MIC breakpoints. Taking advantage of the two isolates with distinct antifungal susceptibility and genetic origins, we performed a biological and genomic comparative study. Besides antifungal susceptibility, strains BJCA001 and BJCA002 showed differences in multiple aspects including morpholo</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-06-19T03:09:31.888Z</modification><creation>2022-02-10T14:27:51.823Z</creation></dates><accession>S-EPMC8172162</accession><cross_references><pubmed>34060424</pubmed><doi>10.1080/21505594.2021.1928410</doi></cross_references></HashMap>